Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the upcoming 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) that will take place May 13-17, 2025, in New Orleans, Louisiana.
'We look forward to sharing a bolus of data at this year's ASGCT as it builds on our scientific body of evidence that support the development of our programmable RNA medicines to shape the future of gene therapy through precise RNA editing, targeted AAV.ai delivery and scalable manufacturing,' stated David Huss, Ph.D., CSO and acting CEO of Shape Therapeutics.
Details of the presentations are below:
Presentation Title: Programmable RNA Editing Enables Precise Protein Modulation in the Central Nervous SystemPresenter: Dr. Alison VanSchoiack, Shape TherapeuticsSession Date and Time: Wednesday, May 14, 2025, 5:30-7:00pm CTSession Title: Wednesday Poster ReceptionSession Room: Poster Hall I2
Presentation Title: Comprehensive Evaluation of TruStable™ vs Transient Production Systems of AAV Vector ManufacturingPresenter: Ken Prentice, Shape TherapeuticsSession Date and Time: Thursday, May 15, 2025, 5:30-7:00pm CTSession Title: Thursday Poster ReceptionSession Room: Poster Hall I2
Oral Presentation Title: Systemically Delivered AAV5-Based Capsid Variants Enable up to 88% Targeted RNA Editing in Primate Brain Presenter: Dr. Rick Sullivan, Shape TherapeuticsSession Date and Time: Friday, May 16, 2025, 1:45-2:00pm CTSession Title: AAV Gene Transfer (B): Ocular, Neurological & Immune Cell SystemsSession Room: NOLA Theater A
Oral Presentation Title: Mechanistic Insights Enhance Multi-Serotype Production in the TruStable™ AAV Producer Cell LinePresenter: Dr. Sandhya Pande, Shape TherapeuticsSession Date and Time: Friday, May 16, 2025, 5:00-5:15pm CT Session Title: AAV Vector Manufacturing: Plasmids & Cell Line DevelopmentSession Room: NOLA Theater C
About Shape Therapeutics
ShapeTX is an AI-driven genomic medicines company focused on creating curative and transformative medicines through its programmable RNA editing technology. By focusing on three differentiated pillars of value, ShapeTX utilizes its RNAfix® technology, targeted AAV.ai delivery system and TruStable™ manufacturing platform to advance a strong internal pipeline of RNA therapeutics across a wide range of diseases, including ABCA4-related diseases and neurological disorders. You can find us at shapetx.com and on LinkedIn and X.
Investor Contact:Anne Marie FieldsPrecision AQannemarie.fields@precisionaq.com
Media Contact:info@shapetx.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
28 minutes ago
- Business Wire
Corstasis Therapeutics Announces Appointment of Sanjeev Narula to its Strategic Advisory Board
HENDERSON, Nev.--(BUSINESS WIRE)--Corstasis Therapeutics Inc. ( a late clinical-stage innovator of therapies that enhance options for the treatment of fluid overload in patients with cardiorenal and hepatic diseases, with the intent of lowering the overall cost of care, today announced that life science executive Sanjeev Narula has joined the company's Strategic Advisory Board. Corstasis Therapeutics Announces Appointment of Sanjeev Narula to its Strategic Advisory Board Share 'Sanjeev's extensive strategic, financial and operational experience in large commercial-stage pharmaceutical companies make him a tremendous addition to our strategic advisory board,' said Benjamin Esque, Chairman and Chief Executive Officer of Corstasis Therapeutics Inc. 'We expect Corstasis will benefit greatly from Sanjeev's advice as we prepare our commercial strategy and pre-launch activities for Enbumyst™ ahead of its potential approval in September.' Mr. Narula most recently served as the Chief Financial Officer of Intra-Cellular Therapies, Inc., which he joined in 2024. During his tenure, he played a crucial role in expanding the commercial and operational capabilities of the company , which culminated in the successful acquisition of Intra-Cellular Therapies by Johnson & Johnson for $14.6 billion less than a year later. Before Intra-Cellular, Mr. Narula served as the first Chief Financial Officer of Viatris, which he joined in 2020 when the company was formed through the combination of Mylan and Upjohn, a division of Pfizer Inc. Prior to Viatris, he served as Chief Financial Officer at Upjohn, overseeing finance, procurement and business technology for all functions of the business, and held several other financial leadership positions during his 16 years at Pfizer. 'I am excited to join Corstasis as a strategic advisor at this critical inflection point in the company's journey, and look forward to contributing to its growth and capital strategy as it prepares for the potential launch of Enbumyst™,' said Mr. Narula. About Corstasis Therapeutics Corstasis Therapeutics is a late clinical-stage biopharmaceutical company whose mission is to develop and commercialize enhanced outpatient treatment options for patients with cardiorenal and hepatic diseases, with the intent of improving outcomes and reducing overall healthcare costs. Our lead product, Enbumyst™ bumetanide nasal spray, has been developed for the short-term treatment of edema associated with congestive heart failure, liver and kidney disease, with an anticipated PDUFA action date of September 14, 2025. For more information, please visit
Business Wire
an hour ago
- Business Wire
Expro Unveils Its Most Advanced Brute ® Packer System for Deepwater Wells
HOUSTON--(BUSINESS WIRE)--Expro (NYSE:XPRO), a leading provider of energy services, has launched its most advanced BRUTE ® High-Pressure, High Tensile Packer System, designed to help operators work more efficiently and confidently in the extreme conditions of deepwater wells. Engineered for the highest differential pressures in the market, this new technology gives operators the flexibility to set higher in the wellbore - saving rig time, reducing operational risk, and simplifying regulatory compliance. The introduction of the BRUTE ® Armor Packer marks a major milestone in the continued evolution of Expro's BRUTE ® product line. With unmatched versatility, this innovation positions Expro as the only provider capable of supporting 20k deepwater projects at this level. When deployed with the BRUTE ® 2 Storm Valve, it forms the industry's highest-rated Storm/Service Packer and Valve combination currently available. As a recognized leader in deepwater downhole solutions, Expro was commissioned by a super-major energy company for a high-spec 20k development in the Gulf of America. The inaugural use of the technology confirmed its pressure integrity and performance under extreme downhole conditions resulting in the release and first successful deployment of the 12,850 psid-rated 12.25' BRUTE ® Armor Packer System in April 2025. Building on the successful deployment of the 12.25' Packer System, Expro has also introduced a new 20'/22' Packer System addressing historical challenges of 20' and 22' retrievable mechanical packer systems, often constrained by internal diameter (ID) limitations, such as subsea high-pressure wellhead housings and supplemental casing adapters. Featuring twice the element expansion capability of traditional mechanical packers, the new system delivers efficient, reliable performance for casing testing, suspension, and squeeze applications, all without compromising operational effectiveness. The first deployment of the 20'/22' Packer System recently took place in June 2025, during a high-profile offshore campaign for a super-major operator in the Gulf of America. The packer passed through restrictions in the high-pressure wellhead housing and supplemental casing adapter before being installed in a larger ID below both components. It achieved full element expansion and pressure integrity on the first attempt validating the tool's enhanced expansion capability, enabling efficient casing isolation while reducing rig time and operational risk. Jeremy Angelle, Vice President of Well Construction commented: 'This launch firmly establishes Expro's BRUTE ® Packers as the industry benchmark for deepwater storm and test packers in terms of pressure and tensile strength. The modular toolset provides unparalleled flexibility, making it the most adaptable solution on the market and positions Expro as the partner of choice for next-generation 20k deepwater developments. 'We're not just meeting the industry's toughest standards - we're defining them.' Notes to Editors Working for clients across the well life cycle, Expro is a leading provider of energy services, offering cost-effective, innovative solutions and what the Company considers to be best-in-class safety and service quality. The Company's extensive portfolio of capabilities spans well construction, well flow management, subsea well access, and well intervention and integrity solutions. With roots dating to 1938, Expro has approximately 8,500 employees and provides services and solutions to leading exploration and production companies in both onshore and offshore environments in more than 50 countries. For more information, please visit and connect with Expro on Twitter @ExproGroup and LinkedIn @Expro. This press release, and oral statements made from time to time by representatives of the Company, may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding, among other things, the success, safety, efficiency and sustainability of the Company's well construction technologies, the Company's environmental, social and governance goals, targets and initiatives, and future growth, and are indicated by words or phrases such as "anticipate," "outlook," "estimate," "expect," "project," "believe," "envision," "goal," "target," "can," "will," and similar words or phrases. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from the future results, performance or achievements expressed in or implied by such forward-looking statements. Forward-looking statements are based largely on the Company's expectations and judgments and are subject to certain risks and uncertainties, many of which are unforeseeable and beyond our control. The factors that could cause actual results, performance or achievements to materially differ include, among others the risk factors identified in the Company's Annual Report on Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, historical practice, or otherwise.
Business Upturn
2 hours ago
- Business Upturn
Minda Corporation partners with Qualcomm to develop next-gen smart cockpit solutions for Indian automotive market
By Aditya Bhagchandani Published on July 23, 2025, 11:31 IST Minda Corporation Limited, the flagship company of Spark Minda Group, announced a strategic technology collaboration with Qualcomm Technologies, Inc. to design and develop advanced smart cockpit solutions for the Indian automotive sector. Under this partnership, Minda Corporation will build next-generation cockpit domain controllers powered by the Snapdragon® Cockpit Platform, part of Qualcomm's Digital Chassis™ solutions. These advanced platforms aim to enhance in-vehicle experiences with rich multimedia, AI-driven interfaces, cloud integration, and seamless vehicle connectivity, enabling software-defined vehicles (SDVs). Speaking on the collaboration, Suresh D., Group CTO of Minda Corporation, said: 'This partnership marks a significant milestone in our journey to deliver next-generation digital cockpit solutions. Leveraging Qualcomm's cutting-edge automotive platforms allows us to offer intuitive human-machine interfaces, multi-display integration, and software-defined cockpit architectures built on Android and QNX. It aligns with our vision of delivering intelligent, connected, and user-centric experiences for OEMs and end-users.' Savi Soin, Senior Vice President and India President of Qualcomm Technologies, added: 'We are excited to collaborate with Spark Minda to deliver advanced, localized cockpit solutions tailored to India's evolving automotive landscape using our Snapdragon Cockpit Platform. Together, we aim to redefine the in-vehicle experience for Indian consumers.' These solutions are expected to bring premium features such as responsive displays, immersive audio, and enhanced cloud and AI integration to vehicles in India, while meeting the growing demand for connectivity and personalization. Minda Corporation is a leading automotive component manufacturer with a strong presence in India and abroad, offering products across mechatronics, connected systems, plastics, and interiors for 2-wheelers, passenger vehicles, and commercial vehicles. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
